Tilray Brands (TLRY) Depreciation & Amortization - Total (2018 - 2019)
Tilray Brands (TLRY) reported Depreciation & Amortization - Total of $8.5 million for Q4 2019, up 190.21% on a YoY basis from $2.9 million in Q4 2018, and up 4235.53% quarter-over-quarter from $197000.0 in Q3 2019.
Tilray Brands (TLRY) Depreciation & Amortization - Total (2018 - 2019) Analysis & Trends
Tilray Brands has reported Depreciation & Amortization - Total for 2 years, with the latest figure at $8.5 million in Q4 2019.
- For the quarter ending Q4 2019, Depreciation & Amortization - Total rose 190.21% year-over-year to $8.5 million; the trailing twelve-month figure through Aug 2020 stood at $8.5 million (changed N/A YoY), and the FY2020 full-year result was $12.5 million, up 34.76% from the prior year.
- Depreciation & Amortization - Total for Q4 2019 stood at $8.5 million, up from $197000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was $8.5 million in Q4 2019, with the low at $29000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Tilray Brands | - | - | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 8.54 Mn |
| Sep 30, 2019 | 197,000.00 |
| Mar 31, 2019 | 305,000.00 |
| Dec 31, 2018 | 2.94 Mn |
| Sep 30, 2018 | 208,000.00 |
| Jun 30, 2018 | 157,000.00 |
| Mar 31, 2018 | 29,000.00 |